Domestic pharma giants– Cipla, Hetero got DCGI’s nod to manufacture, sell anti-viral Remdesivir drug to fight COVID ANI News

New Delhi [India], June 21 (ANI): In a significant development, India’s top drug regulator has given nod to two domestic pharmaceutical companies–Cipla and Hetero for marketing authorization of anti-viral drug Remdesivir only for “restricted emergency use” o? Read More